Brief: Amicus Therapeutics Announces Approval Of Pombiliti®
25/06/2025 12:01
June 25 (Reuters) - Amicus Therapeutics Inc FOLD.O: AMICUS THERAPEUTICS ANNOUNCES APPROVAL OF POMBILITI® (CIPAGLUCOSIDASE ALFA) + OPFOLDA® (MIGLUSTAT) IN JAPAN Source text: ID:nGNX1mmrPf Further company coverage: FOLD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amicus Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates